Inventor
HUNTER MICHAEL GEORGE
GB21 patents
⚠️ This page may combine multiple inventors who share the name “HUNTER MICHAEL GEORGE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRITISH BIOTECH PHARM
13 patentsUS6057123AMay 2, 2000
Stem cell inhibiting proteins
BRITISH BIOTECH PHARM66 citations95
US6423690B1Jul 23, 2002
Antibacterial agents
BRITISH BIOTECH PHARM19 citations91
US5856301AJan 5, 1999
Stem cell inhibiting proteins
BRITISH BIOTECH PHARM21 citations91
US6441042B1Aug 27, 2002
Hydroxamic acid derivatives as antibacterials
BRITISH BIOTECH PHARM12 citations73
US6908911B1Jun 21, 2005
Antibacterial agents
BRITISH BIOTECH PHARM8 citations72
US6787522B2Sep 7, 2004
Antibacterial agents
BRITISH BIOTECH PHARM11 citations72
US5965697AOct 12, 1999
Disaggregated mutant human RANTES
BRITISH BIOTECH PHARM16 citations72
US5925568AJul 20, 1999
Release and mobilization of haematopoietic cells
BRITISH BIOTECH PHARM10 citations70
US6545051B1Apr 8, 2003
Antibacterial hydroxamic acid derivatives
BRITISH BIOTECH PHARM3 citations62
US7323448B2Jan 29, 2008
Antibacterial agents
BRITISH BIOTECH PHARM1 citations61
US7148198B2Dec 12, 2006
Antibacterial agents
BRITISH BIOTECH PHARM1 citations61
US7323563B2Jan 29, 2008
Hydroxamic acid derivatives as antibacterials
BRITISH BIOTECH PHARM0 citations49
US6992190B2Jan 31, 2006
Hydroxamic acid derivatives as antibacterials
BRITISH BIOTECH PHARM0 citations49
MIDDLEMISS DAVID
4 patentsUS8314257B2Nov 20, 2012
Treatment of CRTH2-mediated diseases and conditions
MIDDLEMISS DAVID6 citations82
US8198314B2Jun 12, 2012
Treatment of CRTH2-mediated diseases and conditions
MIDDLEMISS DAVID7 citations82
US8163936B2Apr 24, 2012
Treatment of CRTH2-mediated diseases and conditions
MIDDLEMISS DAVID6 citations82
US8163931B2Apr 24, 2012
Treatment of CRTH2-mediated diseases and conditions
MIDDLEMISS DAVID6 citations82